Gilead Sciences Commits to Veeva Vault CRM
Veeva Systems (NYSE:VEEV) announced that Gilead Sciences has committed to implementing Veeva Vault CRM, expanding their existing partnership. The Vault CRM Suite will serve as the foundation for Gilead's commercial execution, featuring advanced AI capabilities including pre-call planning, compliant free text, and voice control functionalities.
This strategic partnership aims to enhance Gilead's commercial operations through Veeva's AI-powered CRM platform, which is designed to improve efficiency and effectiveness in commercial execution. The collaboration represents a significant expansion of the relationship between the two companies, with Gilead's global CIO expressing enthusiasm about exploring Veeva AI's potential.
Veeva Systems (NYSE:VEEV) ha annunciato che Gilead Sciences ha deciso di adottare Veeva Vault CRM, ampliando la collaborazione già esistente. La Vault CRM Suite costituirà la base per l'esecuzione commerciale di Gilead, includendo avanzate funzionalità di IA come la pianificazione pre-visit, l'elaborazione conforme del testo libero e il controllo vocale.
Questa partnership strategica mira a potenziare le operazioni commerciali di Gilead tramite la piattaforma CRM potenziata dall'IA di Veeva, pensata per migliorare efficienza ed efficacia nell'esecuzione commerciale. La collaborazione rappresenta un'importante estensione del rapporto tra le due aziende, con il CIO globale di Gilead che si è detto entusiasta di esplorare il potenziale dell'IA di Veeva.
Veeva Systems (NYSE:VEEV) anunció que Gilead Sciences se ha comprometido a implementar Veeva Vault CRM, ampliando su asociación existente. La Vault CRM Suite servirá como base para la ejecución comercial de Gilead, incorporando capacidades avanzadas de IA como la planificación previa a las visitas, texto libre compliant y control por voz.
Esta alianza estratégica busca mejorar las operaciones comerciales de Gilead mediante la plataforma CRM potenciada por IA de Veeva, diseñada para aumentar la eficiencia y la eficacia en la ejecución comercial. La colaboración supone una expansión significativa de la relación entre ambas compañías, y el CIO global de Gilead ha mostrado entusiasmo por explorar el potencial de la IA de Veeva.
Veeva Systems (NYSE:VEEV)는 Gilead Sciences가 기존 파트너십을 확대해 Veeva Vault CRM 도입을 확정했다고 발표했습니다. Vault CRM Suite는 Gilead의 상업적 실행의 토대가 되며, 사전 방문 계획, 규정 준수가 가능한 자유 텍스트 처리 및 음성 제어 기능 등 고급 AI 기능을 포함합니다.
이 전략적 파트너십은 Veeva의 AI 기반 CRM 플랫폼을 통해 Gilead의 상업 운영 효율성과 효과성을 향상시키는 것을 목표로 합니다. 이번 협력은 양사 관계의 중요한 확장으로, Gilead의 글로벌 CIO는 Veeva AI의 가능성을 탐색하는 데 큰 기대를 표했습니다.
Veeva Systems (NYSE:VEEV) a annoncé que Gilead Sciences s'est engagé à déployer Veeva Vault CRM, élargissant ainsi leur partenariat existant. La Vault CRM Suite servira de base à l'exécution commerciale de Gilead, intégrant des capacités avancées d'IA telles que la planification pré-visite, le texte libre conforme et les fonctions de commande vocale.
Ce partenariat stratégique vise à renforcer les opérations commerciales de Gilead grâce à la plateforme CRM alimentée par l'IA de Veeva, conçue pour améliorer l'efficacité et l'efficience de l'exécution commerciale. Cette collaboration représente une expansion significative de la relation entre les deux entreprises, et le CIO mondial de Gilead s'est déclaré enthousiaste à l'idée d'explorer le potentiel de l'IA de Veeva.
Veeva Systems (NYSE:VEEV) gab bekannt, dass Gilead Sciences sich verpflichtet hat, Veeva Vault CRM einzuführen und damit die bestehende Partnerschaft ausweitet. Die Vault CRM Suite wird die Grundlage für Gileads kommerzielle Umsetzung bilden und fortschrittliche KI-Funktionen wie Pre-Call-Planung, konforme Freitextverarbeitung und Sprachsteuerung bieten.
Diese strategische Partnerschaft zielt darauf ab, Gileads kommerzielle Abläufe durch Veevas KI-gestützte CRM-Plattform zu verbessern, die darauf ausgelegt ist, Effizienz und Effektivität in der kommerziellen Umsetzung zu steigern. Die Zusammenarbeit stellt eine bedeutende Erweiterung der Beziehung zwischen den beiden Unternehmen dar; Gileads globaler CIO zeigt sich begeistert, das Potenzial der Veeva-AI zu erkunden.
- Strategic partnership with major pharmaceutical company Gilead Sciences
- Expansion of existing customer relationship demonstrating strong client retention
- Implementation of AI-powered CRM solution showing product innovation
- None.
Next generation CRM with deep capabilities and agentic AI
"Gilead is a leader in life changing medicines and has been a pioneer of major scientific advancements in virology, inflammation, and oncology," said Veeva CEO Peter Gassner. "We are honored to be a strategic partner to Gilead and extend that partnership to Vault CRM."
"We are excited to expand our long-standing partnership with Veeva by moving to Vault CRM," said Anna Åsberg, global CIO at Gilead Sciences. "We share a deep commitment to advancing medicine and are excited to explore the potential of Veeva AI to help drive commercial execution to the next level."
Vault CRM is part of the Vault CRM Suite of applications that provides the foundation for commercial execution. Veeva AI for Vault CRM delivers multiple AI agents, including pre-call planning, compliant free text, and voice control, to drive commercial efficiency and effectiveness.
About Veeva Systems
Veeva delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. Gilead operates in more than 35 countries worldwide, with headquarters in
Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2025, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.
Contact:
Maria Scurry
Veeva Systems
maria.scurry@veeva.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/gilead-sciences-commits-to-veeva-vault-crm-302551872.html
SOURCE Veeva Systems
FAQ
What is the new partnership between Veeva Systems (NYSE:VEEV) and Gilead Sciences?
What AI features does Veeva's Vault CRM offer to Gilead Sciences?
How will Veeva's Vault CRM benefit Gilead Sciences' operations?
Who are the key executives involved in the Veeva-Gilead CRM partnership?
What is Veeva Vault CRM Suite?
